TrumpRX.gov is a federal initiative that will let consumers purchase brand-name drugs directly from manufacturers—without using insurance. The program will start with Pfizer, which has agreed to offer its medications at 50% lower prices on average, according to the White House. The site is expected to launch in 2026, with plans to include other pharmaceutical companies in future deals. According to federal officials, the discounts are based on list prices, which are already inflated compared to what insurance companies negotiate. Medicaid patients already pay low drug prices, so taxpayer savings may be minimal .